Please use this identifier to cite or link to this item:
https://hdl.handle.net/1959.11/6537
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Westaway, Kerrie Patricia | en |
dc.contributor.author | Cruickshank, Mary | en |
dc.contributor.author | Roberts, Greg | en |
dc.date.accessioned | 2010-09-16T16:20:00Z | - |
dc.date.created | 2007 | en |
dc.date.issued | 2008 | - |
dc.identifier.uri | https://hdl.handle.net/1959.11/6537 | - |
dc.description.abstract | The clinical effectiveness of warfarin as an anticoagulant in the primary and secondary prevention and treatment of thromboembolic disease has long been established. With the advent of anticoagulant treatment for atrial fibrillation, the number of patients receiving warfarin therapy has dramatically increased. Conversely, warfarin is a potentially hazardous drug with research indicating that patients are at the greatest risk of bleeding during the first three months of treatment and that anticoagulants have undergone the greatest increase in adverse drug reactions in Australia since 1981, revealing that this is a highly prevalent, costly process that will continue to grow in the future. Therefore, this study investigated the current process of management of warfarin therapy through the hospital/community interface from initiation for a period of five months, or less if warfarin therapy was ceased prior to this time. It was anticipated that this study would clarify unresolved key issues of warfarin therapy during this time in order to improve clinical outcomes and consequently reduce costs. | en |
dc.language | en | en |
dc.title | An Investigation of the Management of the International Normalised Ratio (INR) in Warfarin Therapy During the Initial Five Months of Treatment | en |
dc.type | Thesis Doctoral | en |
dcterms.accessRights | UNE Green | en |
local.contributor.firstname | Kerrie Patricia | en |
local.contributor.firstname | Mary | en |
local.contributor.firstname | Greg | en |
dcterms.RightsStatement | Copyright 2007 - Kerrie Patricia Westaway | en |
dc.date.conferred | 2008 | en |
local.thesis.degreelevel | Doctoral | en |
local.thesis.degreename | Doctor of Philosophy | en |
local.contributor.grantor | University of New England | en |
local.profile.school | School of Health | en |
local.profile.email | mmacarty@une.edu.au | en |
local.output.category | T2 | en |
local.record.place | au | en |
local.record.institution | University of New England | en |
local.identifier.epublicationsrecord | vtls086382501 | en |
local.access.fulltext | Yes | en |
local.contributor.lastname | Westaway | en |
local.contributor.lastname | Cruickshank | en |
local.contributor.lastname | Roberts | en |
dc.identifier.staff | une-id:mmacarty | en |
local.profile.role | author | en |
local.profile.role | supervisor | en |
local.profile.role | supervisor | en |
local.identifier.unepublicationid | une:6695 | en |
dc.identifier.academiclevel | Academic | en |
local.title.maintitle | An Investigation of the Management of the International Normalised Ratio (INR) in Warfarin Therapy During the Initial Five Months of Treatment | en |
local.output.categorydescription | T2 Thesis - Doctorate by Research | en |
local.thesis.borndigital | no | en |
local.search.author | Westaway, Kerrie Patricia | en |
local.search.supervisor | Cruickshank, Mary | en |
local.search.supervisor | Roberts, Greg | en |
local.open.fileurl | https://rune.une.edu.au/web/retrieve/140f532a-25c8-40b7-8415-d7282ca1eaaa | en |
local.open.fileurl | https://rune.une.edu.au/web/retrieve/5fab8826-4d4e-4c9a-834e-93d4bc1d3a06 | en |
local.open.fileurl | https://rune.une.edu.au/web/retrieve/dcc70fc4-d67c-4008-ae8e-18c260259c05 | en |
local.open.fileurl | https://rune.une.edu.au/web/retrieve/1ca8f7e4-a850-4d6d-976b-fde4093c3359 | en |
local.open.fileurl | https://rune.une.edu.au/web/retrieve/bfd4df3f-67de-4980-9566-4751ca9d1223 | en |
local.open.fileurl | https://rune.une.edu.au/web/retrieve/4982f2a5-38d9-4b23-80b2-35b564935136 | en |
local.open.fileurl | https://rune.une.edu.au/web/retrieve/9b575670-4889-4bad-8e9e-34ab139a0baa | en |
local.uneassociation | Yes | en |
local.year.conferred | 2008 | en |
local.fileurl.open | https://rune.une.edu.au/web/retrieve/140f532a-25c8-40b7-8415-d7282ca1eaaa | en |
local.fileurl.open | https://rune.une.edu.au/web/retrieve/4982f2a5-38d9-4b23-80b2-35b564935136 | en |
local.fileurl.open | https://rune.une.edu.au/web/retrieve/9b575670-4889-4bad-8e9e-34ab139a0baa | en |
local.fileurl.open | https://rune.une.edu.au/web/retrieve/bfd4df3f-67de-4980-9566-4751ca9d1223 | en |
local.fileurl.open | https://rune.une.edu.au/web/retrieve/dcc70fc4-d67c-4008-ae8e-18c260259c05 | en |
local.fileurl.open | https://rune.une.edu.au/web/retrieve/1ca8f7e4-a850-4d6d-976b-fde4093c3359 | en |
local.fileurl.open | https://rune.une.edu.au/web/retrieve/5fab8826-4d4e-4c9a-834e-93d4bc1d3a06 | en |
Appears in Collections: | School of Health Thesis Doctoral |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
open/SOURCE06.pdf | Thesis, part 3 | 4.58 MB | Adobe PDF Download Adobe | View/Open |
open/SOURCE05.pdf | Thesis, part 2 | 5.12 MB | Adobe PDF Download Adobe | View/Open |
open/SOURCE07.pdf | Thesis, part 4 | 3.78 MB | Adobe PDF Download Adobe | View/Open |
open/SOURCE04.pdf | Thesis, part 1 | 1 MB | Adobe PDF Download Adobe | View/Open |
open/SOURCE08.pdf | Thesis, part 5 | 4.29 MB | Adobe PDF Download Adobe | View/Open |
open/SOURCE03.pdf | Abstract | 7.54 MB | Adobe PDF Download Adobe | View/Open |
open/SOURCE09.pdf | Thesis, part 6 | 2.51 MB | Adobe PDF Download Adobe | View/Open |
Page view(s)
2,528
checked on Jun 11, 2023
Download(s)
656
checked on Jun 11, 2023
Items in Research UNE are protected by copyright, with all rights reserved, unless otherwise indicated.